IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.
about
MMP19 is essential for T cell development and T cell-mediated cutaneous immune responsesCD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses.Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots.An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.Transgenic Eimeria mitis expressing chicken interleukin 2 stimulated higher cellular immune response in chickens compared with the wild-type parasites.Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine.Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant deliveryRepeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys.Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer modelSignal 0 for guided priming of CTLs: NKT cells do it too.The potential of CD4 T-cell memory.Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles.FoxP3⁺ regulatory CD4 T cells control the generation of functional CD8 memory.IL-12 immunotherapy of murine leukaemia: comparison of systemic versus gene modified cell therapy.Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8(+) T Cell Responses Independently of Transgene Expression in DCs.The effect of feed supplementation with Zakarpacki zeolite (clinoptilolite) on percentages of T and B lymphocytes and cytokine concentrations in poultry.T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.Agonistic anti-CD40 promotes early development and increases the incidence of severe thyroid epithelial cell hyperplasia (TEC H/P) in CD4-/- mice.CD154+ CD4+ T-cell dependence for effective memory influenza virus-specific CD8+ T-cell responses.T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy.CD40L co-stimulation from CD8+ to CD4+ effector memory T cells supports CD4+ expansion.Potent CTL induction by a whole cell pertussis vaccine in anti-tumor peptide immunotherapy.
P2860
Q33340257-17D67E29-3A51-4E3A-9F3C-27D88B595ADAQ33591684-DF285563-5F9B-4E62-8912-5D640A4A708AQ33942207-DD1E13BA-5D19-46E7-85AD-47EABC897F05Q35266959-949B41FC-7797-47BB-ABF5-960E81125D09Q35672493-7E7A92BC-72DA-4EA8-B326-E31389E20545Q35772109-9E9AEB19-87A2-4D2A-A60E-D8D1A9067867Q35928216-16F183C1-B33A-4DB1-8AC1-9539D7E350A0Q36304389-E5013734-D6AB-40B8-AA2F-15D0C61B884CQ36345439-17DEAD13-F8F1-4B92-AC33-A80897A65DF3Q37714323-24FD8427-28BB-48E2-83F8-88BA609C8555Q37717706-5B98D8C3-5201-43BA-A191-895DDCC19952Q39161562-77C60E5C-2DE4-4DF7-96E1-569C3777BBD3Q39300976-30FD503C-4ED8-49E7-8D6D-64F641FEA0C4Q39961838-1C2DDD66-DA2C-4316-A414-2B60CE540210Q40117829-D4A08C7C-DB42-4501-BE3E-EC2324D47DA0Q40279677-658A721D-C837-4217-996F-8E49E8AE46C6Q41774005-8A8A76F5-9ABE-43B3-9C17-7792915538EDQ42054432-31D0B629-9170-4AAB-AF88-0B3D5541A059Q42221737-C9633315-76AC-4C01-A2AC-C23FCF54DE77Q45951645-D238128E-0A7A-4C06-A2A1-AF904879046AQ51027458-075F1ACD-F789-4BA2-8047-6A490DBBCBC8Q51973490-DB9D31A6-A140-4833-9123-8EA1F89FCDB8
P2860
IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
IL-2 is required for the activ ...... ia antigen cross-presentation.
@en
IL-2 is required for the activ ...... ia antigen cross-presentation.
@nl
type
label
IL-2 is required for the activ ...... ia antigen cross-presentation.
@en
IL-2 is required for the activ ...... ia antigen cross-presentation.
@nl
prefLabel
IL-2 is required for the activ ...... ia antigen cross-presentation.
@en
IL-2 is required for the activ ...... ia antigen cross-presentation.
@nl
P2093
P1476
IL-2 is required for the activ ...... ia antigen cross-presentation.
@en
P2093
Deborah Braun
Heather K Morris
Hélène Saklani
James P Di Santo
Matthew L Albert
Nathalie E Blachère
Robert B Darnell
P304
P356
10.4049/JIMMUNOL.176.12.7288
P407
P577
2006-06-01T00:00:00Z